Green Handbag


Johnson & Johnson Vaccine Limited by The FDA.

By Mr. Marathi

The Special Inspector General for Pandemic Recovery office delivered its quarterly report last week, which says its Office of Investigations is chipping away at 27 open cases. That is fourfold its casework since the year before.

The Food and Drug Administration on Thursday limited its authorization of the Johnson & Johnson vaccine

people 18 years old and more established for whom other approved or endorsed COVID-19 antibodies are not available or clinically suitable, and to people 18 years old and more seasoned who choose to get the Janssen COVID-19 immunization since they would some way or another not get a COVID-19 immunization.

The FDA made this decision because of a rare and dangerous clotting condition.

Last spring, the FDA and Centers for Disease Control and Prevention recommended a pause of the vaccine over the clotting condition. The pause was lifted after 10 days and a warning label was added about the potential risks.

Secretary of State Antony Blinken, who is fully vaccinated and boosted, tested positive for coronavirus on Wednesday, making him the latest high-profile government official to do so.

The federal government “faces an unsustainable fiscal future,” and while the “underlying conditions” were around well before the pandemic, the “government’s extensive fiscal response to the COVID-19 pandemic accelerated the growth in federal debt,”